154 related articles for article (PubMed ID: 31676217)
41. Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent?
Parikh KH; Kirtane AJ
Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):416-417. PubMed ID: 29104001
[No Abstract] [Full Text] [Related]
42. [The treatment of stable coronary artery disease: always optimal medical therapy, coronary revascularization only on indication].
van den Brink RBA; Verheul HA
Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736371
[TBL] [Abstract][Full Text] [Related]
43. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
[TBL] [Abstract][Full Text] [Related]
45. Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies.
Xiao Y; He S; Zhang Z; Feng H; Cui S; Wu J
Med Sci Monit; 2018 Dec; 24():9166-9176. PubMed ID: 30557296
[TBL] [Abstract][Full Text] [Related]
46. CABG not PCI for adults with diabetes.
BMJ; 2012 Nov; 345():e7610. PubMed ID: 23148328
[No Abstract] [Full Text] [Related]
47. Overview of systematic reviews on invasive treatment of stable coronary artery disease.
Kuukasjärvi P; Malmivaara A; Halinen M; Hartikainen J; Keto PE; Talvensaari T; Tierala I; Mäkelä M
Int J Technol Assess Health Care; 2006; 22(2):219-34. PubMed ID: 16571198
[TBL] [Abstract][Full Text] [Related]
48. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
[TBL] [Abstract][Full Text] [Related]
49. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
[TBL] [Abstract][Full Text] [Related]
50. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
Kiernan TJ; Prasad A; Gersh BJ
Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
[No Abstract] [Full Text] [Related]
51. High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.
Ndrepepa G; Colleran R; Braun S; Cassese S; Hieber J; Fusaro M; Kufner S; Ott I; Byrne RA; Husser O; Hengstenberg C; Laugwitz KL; Schunkert H; Kastrati A
J Am Coll Cardiol; 2016 Nov; 68(21):2259-2268. PubMed ID: 27884243
[TBL] [Abstract][Full Text] [Related]
52. Management Strategies for Noncardiac Surgery Following a Coronary Artery Event.
Whayne TF; Saha SP
Curr Cardiol Rep; 2018 Jan; 20(1):3. PubMed ID: 29353319
[TBL] [Abstract][Full Text] [Related]
53. Medical Therapy Induced Regression of Plaque in a Female Patient with ASCVD.
Guan S; Zhang Y; Wang B; Li W
Int Heart J; 2019 Jan; 60(1):175-177. PubMed ID: 30464115
[TBL] [Abstract][Full Text] [Related]
54. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
Mood GR; Bavry AA; Roukoz H; Bhatt DL
Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
56. Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
Toyota T; Morimoto T; Shiomi H; Yamaji K; Ando K; Ono K; Shizuta S; Saito N; Kato T; Kaji S; Furukawa Y; Nakagawa Y; Kadota K; Horie M; Kimura T;
Heart; 2018 Jun; 104(11):936-944. PubMed ID: 29146627
[TBL] [Abstract][Full Text] [Related]
57. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.
Briguori C; Madonna R; Zimarino M; Calabrò P; Quintavalle C; Salomone M; Condorelli G; De Caterina R
Cardiovasc Drugs Ther; 2016 Oct; 30(5):465-472. PubMed ID: 27358173
[TBL] [Abstract][Full Text] [Related]
58. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
[TBL] [Abstract][Full Text] [Related]
59. [Vascular Behçet disease presenting large right coronary artery pseudoaneurysm after percutaneous coronary intervention( PCI): report of a case].
Komooka M; Higashiue S; Matsubayashi K; Tonda H; Kawahira T; Azuma S; Hiramatsu N; Furuya O
Kyobu Geka; 2013 Aug; 66(9):845-8. PubMed ID: 23917241
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
